Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open Label Extension Study of 8 mg PEG-uricase in Subjects Who Completed Protocols C0405 or C0406 for Symptomatic Gout

NCT01356498 is registered in ClinicalTrials.gov with Savient Pharmaceuticals as lead sponsor.

NCT NCT01356498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01356498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open Label Extension Study of 8 mg PEG-uricase in Subjects Who Completed Protocols C0405 or C0406 for Symptomatic Gout
Lead sponsor
Savient Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
January 31, 2010
Enrollment
151 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

gout